Aug 22 - 23, 2022

Cell Therapy Durability Response Summit, Boston

Dr. James Lederer will be presenting a talk entitled ‘SUPLEXA Therapeutic cells – a highly differentiated non-engineered and tumor agnostic autologous cellular therapy in Phase 1 Testing’ at the Cell Therapy Durability Response Summit in Boston on the afternoon August 23rd at the Hilton Boston Back Bay. He is also participating in a panel discussion afterwards entitled ‘Will moving beyond CAR-αβT and CAR-NK overcome the hurdles to solid tumor cell therapy?’